Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Niccolò Giaj-Levra, Paolo Borghetti, Alessio Bruni, Patrizia Ciammella, Francesco Cuccia, Alessandra Fozza, Davide Franceschini, Vieri Scotti, Stefano Vagge & Filippo Alongi. (2020) Current radiotherapy techniques in NSCLC: challenges and potential solutions. Expert Review of Anticancer Therapy 20:5, pages 387-402.
Read now
Read now
Aman Sharma, Marloes Duijm, Esther Oomen-de Hoop, Joachim G. Aerts, Cornelis Verhoef, Mischa Hoogeman & Joost Jan Nuyttens. (2019) Survival and prognostic factors of pulmonary oligometastases treated with stereotactic body radiotherapy. Acta Oncologica 58:1, pages 74-80.
Read now
Read now
Andrea Lancia, Gianluca Ingrosso, Alessandra Carosi, Luana Di Murro, Emilia Giudice, Sara Cicchetti, Pasquale Morelli, Daniela di Cristino, Claudia Bruni, Alessandra Murgia, Alessandro Cancelli, Irene Turturici, Anjali Iadevaia, Elisabetta Ponti & Riccardo Santoni. (2017) Oligometastatic cancer: stereotactic ablative radiotherapy for patients affected by isolated body metastasis. Acta Oncologica 56:11, pages 1621-1625.
Read now
Read now
Morten Høyer & Ludvig P. Muren. (2012) Stereotactic body radiation therapy – A discipline with Nordic origin and profile. Acta Oncologica 51:5, pages 564-567.
Read now
Read now
Articles from other publishers (35)
Gyu Sang Yoo, Chai Hong Rim, Won Kyung Cho, Jae-Uk Jeong, Eui Kyu Chie, Hyeon-Min Cho, Jun Won Um, Yong Chan Ahn & Jong Hoon Lee. (2023) Metastasis-Directed Local Therapy of Hepatic Oligometastasis from Colorectal Cancer and Future Perspective in Radiation Therapy. Cancer Research and Treatment 55:3, pages 707-719.
Crossref
Crossref
Eric K. Nguyen, Ian Poon, Yee C. Ung, May Tsao, Renee Korol, Alyaa H. Elzibak, Darby Erler, Liying Zhang, Alexander V. Louie & Patrick Cheung. (2023) Toxicity and Efficacy of Multitarget Thoracic Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 115:4, pages 897-905.
Crossref
Crossref
A. Cervantes, R. Adam, S. Roselló, D. Arnold, N. Normanno, J. Taïeb, J. Seligmann, T. De Baere, P. Osterlund, T. Yoshino & E. Martinelli. (2023) Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology 34:1, pages 10-32.
Crossref
Crossref
Bong Kyung Bae, Kyungmi Yang, Jae Myung Noh, Hongryull Pyo & Yong Chan Ahn. (2022) Clinical Outcomes Following Proton and Photon Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer. Cancers 14:17, pages 4152.
Crossref
Crossref
Patricia Mae G. Santos, Xingzhe Li & Daniel R. Gomez. (2022) Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer. Cancers 14:16, pages 3977.
Crossref
Crossref
Reshad Rzazade & Hale Basak Caglar. 2023. Advances in Radiation Oncology in Lung Cancer. Advances in Radiation Oncology in Lung Cancer
739
753
.
Xuguang Chen, Hanbo Chen, Ian Poon, Darby Erler, Serena Badellino, Tithi Biswas, Roi Dagan, Matthew Foote, Alexander V. Louie, Umberto Ricardi, Arjun Sahgal & Kristin J. Redmond. (2021) Late metastatic presentation is associated with improved survival and delayed wide‐spread progression after ablative stereotactic body radiotherapy for oligometastasis. Cancer Medicine 10:18, pages 6189-6198.
Crossref
Crossref
Enrique Gutiérrez, Irving Sánchez, Omar Díaz, Adrián Valles, Ricardo Balderrama, Jesús Fuentes, Brenda Lara, Cipatli Olimón, Víctor Ruiz, José Rodríguez, Luis H. Bayardo, Matthew Chan, Conrad J. Villafuerte, Jerusha Padayachee & Alexander Sun. (2021) Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases. Current Oncology 28:4, pages 2560-2578.
Crossref
Crossref
Yolande Lievens, Matthias Guckenberger, Daniel Gomez, Morten Hoyer, Puneeth Iyengar, Isabelle Kindts, Alejandra Méndez Romero, Daan Nevens, David Palma, Catherine Park, Umberto Ricardi, Marta Scorsetti, James Yu & Wendy A. Woodward. (2020) Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document. Radiotherapy and Oncology 148, pages 157-166.
Crossref
Crossref
Francesco Londero, William Grossi, Angelo Morelli, Orlando Parise, Gianluca Masullo, Cecilia Tetta, Ugolino Livi, Jos G Maessen & Sandro Gelsomino. (2020) Surgery versus stereotactic radiotherapy for treatment of pulmonary metastases. A systematic review of literature. Future Science OA 6:5.
Crossref
Crossref
Yi Tang, Bing Xia, Ruifei Xie, Xiao Xu, Minna Zhang, Kan Wu, Bing Wang & Shenglin Ma. (2020) Timing in combination with radiotherapy and patterns of disease progression in non-small cell lung cancer treated with EGFR-TKI. Lung Cancer 140, pages 65-70.
Crossref
Crossref
S. Corradini, F. Alongi, N. Andratschke, C. Belka, L. Boldrini, F. Cellini, J. Debus, M. Guckenberger, J. Hörner-Rieber, F. J. Lagerwaard, R. Mazzola, M. A. Palacios, M. E. P. Philippens, C. P. J. Raaijmakers, C. H. J. Terhaard, V. Valentini & M. Niyazi. (2019) MR-guidance in clinical reality: current treatment challenges and future perspectives. Radiation Oncology 14:1.
Crossref
Crossref
Xin Wang, Leonid Zamdborg, Hong Ye, Inga S. Grills & Di Yan. (2018) A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer. BMC Cancer 18:1.
Crossref
Crossref
Filippo Alongi, Rosario Mazzola, Vanessa Figlia & Matthias Guckenberger. (2018) Stereotactic body radiotherapy for lung oligometastases: Literature review according to PICO criteria. Tumori Journal 104:3, pages 148-156.
Crossref
Crossref
Masatsugu Hamaji, Takamasa Mitsuyoshi, Akihiko Yoshizawa, Toshihiko Sato, Yukinori Matsuo, Toyofumi-Fengshi Chen-Yoshikawa, Makoto Sonobe, Takashi Mizowaki & Hiroshi Date. (2018) Salvage Pulmonary Metastasectomy for Local Relapse After Stereotactic Body Radiotherapy. The Annals of Thoracic Surgery 105:4, pages e165-e168.
Crossref
Crossref
Keiichi Jingu, Haruo Matsushita, Takaya Yamamoto, Rei Umezawa, Yojiro Ishikawa, Noriyoshi Takahashi, Yu Katagiri, Kazuya Takeda & Noriyuki Kadoya. (2018) Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis. Technology in Cancer Research & Treatment 17, pages 153303381879493.
Crossref
Crossref
T. Yoshino, D. Arnold, H. Taniguchi, G. Pentheroudakis, K. Yamazaki, R.-H. Xu, T.W. Kim, F. Ismail, I.B. Tan, K.-H. Yeh, A. Grothey, S. Zhang, J.B. Ahn, M.Y. Mastura, D. Chong, L.-T. Chen, S. Kopetz, T. Eguchi-Nakajima, H. Ebi, A. Ohtsu, A. Cervantes, K. Muro, J. Tabernero, H. Minami, F. Ciardiello & J.-Y. Douillard. (2018) Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS. Annals of Oncology 29:1, pages 44-70.
Crossref
Crossref
Shankar Siva & Ben J. Slotman. (2017) Stereotactic Ablative Body Radiotherapy for Lung Metastases: Where is the Evidence and What are We Doing With It?. Seminars in Radiation Oncology 27:3, pages 229-239.
Crossref
Crossref
Joelle Helou, Isabelle Thibault, Ian Poon, Andrew Chiang, Suneil Jain, Hany Soliman, Darby Erler, Latifa Yeung & Patrick Cheung. (2017) Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter. International Journal of Radiation Oncology*Biology*Physics 98:2, pages 419-427.
Crossref
Crossref
C. Petersen & T. Gauer. (2017) Möglichkeiten der lokal-ablativen Bestrahlung (SBRT) bei metastasiertem kolorektalem KarzinomLocal ablative radiotherapy of oligometastatic colorectal cancer. Der Radiologe 57:2, pages 105-110.
Crossref
Crossref
Bum-Sup Jang, Hak Jae Kim, Byoung Hyuck Kim, Dong-Wan Kim, Young Tae Kim, Young Whan Kim, Myoung-Jin Jang & Hong-Gyun Wu. (2017) Clinical outcomes of stereotactic ablative radiotherapy in patients with pulmonary metastasis. Japanese Journal of Clinical Oncology 47:1, pages 61-66.
Crossref
Crossref
K. M Stang, F. Alite, C. Small, H. Mar, W. H Adams, A. Sethi, B. Emami & Matthew M Harkenrider. (2016) Novel predictors of esophageal toxicity with stereotactic body radiation therapy for central lung tumors. Journal of Radiation Oncology 5:4, pages 371-377.
Crossref
Crossref
Won Kyung Cho, Jae Myoung Noh, Yong Chan Ahn, Dongryul Oh & Hongryull Pyo. (2016) Radiation Therapy Alone in cT1-3N0 Non-small Cell Lung Cancer Patients Who Are Unfit for Surgical Resection or Stereotactic Radiation Therapy: Comparison of Risk-Adaptive Dose Schedules. Cancer Research and Treatment 48:4, pages 1187-1195.
Crossref
Crossref
Kenichi Omae, Takao Hiraki, Hideo Gobara, Toshihiro Iguchi, Hiroyasu Fujiwara, Yusuke Matsui, Shinichi Toyooka, Takeshi Nagasaka & Susumu Kanazawa. (2016) Long-Term Survival after Radiofrequency Ablation of Lung Oligometastases from Five Types of Primary Lesions: A Retrospective Evaluation. Journal of Vascular and Interventional Radiology 27:9, pages 1362-1370.
Crossref
Crossref
Tony Ibrahim, Lambros Tselikas, Charbel Yazbeck & Joseph Kattan. (2016) Systemic Versus Local Therapies for Colorectal Cancer Pulmonary Metastasis: What to Choose and When?. Journal of Gastrointestinal Cancer 47:3, pages 223-231.
Crossref
Crossref
Jing Zhao, Ellen D. Yorke, Ling Li, Brian D. Kavanagh, X. Allen Li, Shiva Das, Moyed Miften, Andreas Rimner, Jeffrey Campbell, Jinyu Xue, Andrew Jackson, Jimm Grimm, Michael T. Milano & Feng-Ming (Spring) Kong. (2016) Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies. International Journal of Radiation Oncology*Biology*Physics 95:5, pages 1357-1366.
Crossref
Crossref
Atsuya Takeda, Naoko Sanuki, Yuichiro Tsurugai, Yohei Oku & Yousuke Aoki. (2016) Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83–100 Gy in five fractions. Journal of Radiation Research 57:4, pages 400-405.
Crossref
Crossref
Hideomi Yamashita, Yuzuru Niibe, Takaya Yamamoto, Kuniaki Katsui, Keiichi Jingu, Susumu Kanazawa, Atsuro Terahara & Keiichi Nakagawa. (2016) Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases. Japanese Journal of Clinical Oncology 46:7, pages 687-691.
Crossref
Crossref
C. Petersen & T. Gauer. (2016) Möglichkeiten der lokal-ablativen Bestrahlung (SBRT) bei metastasiertem kolorektalem KarzinomLocal ablative radiotherapy of oligometastatic colorectal cancer. Der Onkologe 22:2, pages 115-120.
Crossref
Crossref
Dawn Owen, Kenneth R Olivier, Charles S Mayo, Robert C Miller, Kathryn Nelson, Heather Bauer, Paul D Brown, Sean S Park, Daniel J Ma & Yolanda I Garces. (2015) Outcomes of Stereotactic Body Radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules. Radiation Oncology 10:1.
Crossref
Crossref
Pierina Navarria, Fiorenza De Rose & Anna Maria Ascolese. (2015) SBRT for lung oligometastases: Who is the perfect candidate?. Reports of Practical Oncology & Radiotherapy 20:6, pages 446-453.
Crossref
Crossref
David Benjamin Shultz, Andrea Riccardo Filippi, Juliette Thariat, Francoise Mornex, Billy W. LooJrJr & Umberto Ricardi. (2014) Stereotactic Ablative Radiotherapy for Pulmonary Oligometastases and Oligometastatic Lung Cancer. Journal of Thoracic Oncology 9:10, pages 1426-1433.
Crossref
Crossref
C. Florescu & J. Thariat. (2014) Local ablative treatments of oligometastases from head and neck carcinomas. Critical Reviews in Oncology/Hematology 91:1, pages 47-63.
Crossref
Crossref
Yong Chan Ahn. (2014) Role of Radiation Therapy for Non-small Cell Lung Cancer: Focused on Stereotactic Ablative Radiation Therapy in Stage I. Hanyang Medical Reviews 34:1, pages 45.
Crossref
Crossref
Wataru Takahashi, Hideomi Yamashita, Yuzuru Niibe, Kenshiro Shiraishi, Kazushige Hayakawa & Keiichi Nakagawa. (2012) Stereotactic Body Radiotherapy for Metastatic Lung Cancer as Oligo-Recurrence: An Analysis of 42 Cases. Pulmonary Medicine 2012, pages 1-5.
Crossref
Crossref